Scholefield JH, Moss S, Sufi F, Mangham CM & Hardcastle JD 2002. Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut 50(6): 840–4. Segnan N, Senore C, Andreoni B, Aste H, Bonelli L, Crosta C, Ferraris R, Gasperoni S, Penna A, Risio M, Rossini FP, Sciallero S, Zappa M & Atkin WS 2002. Baseline findings of the Italian multicenter randomized controlled trial of ‘once-only sigmoidoscopy’––SCORE. J Natl <strong>Cancer</strong> Inst 94(23): 1763–72. Selby JV, Friedman GD, Quesenberry CP Jr & Weiss NS 1992. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653–7. Singh H, Turner D, Xue L, Targownik LE & Bernstein CN 2006. Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. JAMA 295(20): 2366–73. St John DJ, Young GP, McHutchison JG, Deacon MC & Alexeyeff MA 1992. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia. Ann Intern Med 117: 376–82. Tong S, Hughes K, Oldenburg B & Del Mar C 2004. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing? Intern Med J 34(9–10): 532–8. Towler B, Irwig L, Glasziou P, Weller D & Silagy C 1998. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 317: 559–65. Turner GB, Chin MW, Foster NM, Emery J & Forbes GM 2006. Attitudes of Western Australian general practitioners to colorectal cancer screening. Med J Aust 185(4): 237. UK Flexible Sigmoidoscopy Screening Trial Investigators (UKSSTI) 2002. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 359(9314): 1291–300. US Preventive Services Task Force (USPSTF) 2002. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137(2): 129–31. Valery PC, Coory M, Stirling J & Green AC 2006. <strong>Cancer</strong> diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet 367(9525): 1842–8. Van Dam J, Cotton P, Johnson CD, McFarland BG, Pineau BC, Provenzale D, Ransohoff D, Rex D, Rockey D & Wootton FT III 2004. AGA future trends report: CT colonography. Gastroenterology 127(3): 970–84. Viiala CH, Zimmerman M, Cullen DJ & Hoffman NE 2003. Complication rates of colonoscopy in an Australian teaching hospital environment. Intern Med J 33(8): 355–9. Wardle J, Miles A & Atkin W 2005. Gender differences in utilization of colorectal cancer screening. J Med Screen 12(1): 20–7. Wardle J, Taylor T, Sutton S & Atkin A 1999. Does publicity about cancer screening raise fear of cancer? Randomised trial of the psychological effect of information about cancer screening. BMJ 319(7216): 1037–8. Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Rawlins M, Vessey M & Wainwright P 1995. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 310(6983): 827–30. Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC & Gohagan JK 2005. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl <strong>Cancer</strong> Inst 97(13): 989–97. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA & Mayer RJ 1997. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 112: 594–642. Woolcott Research 2004. A qualitative evaluation of opinions, attitudes and behaviours influencing the Bowel <strong>Cancer</strong> Screening Pilot Program. Final report. Canberra: Australian Government Department of Health and Ageing. World <strong>Cancer</strong> Research Fund (WCRF) & American Institute for <strong>Cancer</strong> Research (AICR) 1997. Summary: food nutrition and the prevention of cancer: a global perspective. Washington, DC: AICR. <strong>National</strong> <strong>Cancer</strong> <strong>Prevention</strong> <strong>Policy</strong> 2007 – 09 15 B o w e l c a n c e r
Young GP, Macrae FA & St John DJB 1996. Clinical methods for early detection: basis, use, and evaluation. In <strong>Prevention</strong> and early detection of colorectal cancer, eds GP Young, P Rozen & B Levin. London: WB Saunders Company. Young GP, St John DJ, Winawer SJ & Rozen P 2002. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97(10): 2499–507. 1 0 Section Two: Screening to detect cancer early
- Page 1 and 2:
National Cancer Prevention Policy 2
- Page 3 and 4:
The Cancer Council Australia Member
- Page 5 and 6:
Overweight and obesity 86 Introduct
- Page 7 and 8:
A b b r e v i a t i o n s AACR Aust
- Page 9 and 10:
T h e N a t i o n a l C a n c e r P
- Page 11 and 12:
increase their understanding of man
- Page 13 and 14:
T o b a c c o Introduction 12 Secti
- Page 15 and 16:
Figure 1.1 Number of Australians wh
- Page 17 and 18:
(16.3%) continues the trends observ
- Page 19 and 20:
in the longer-term future, when hea
- Page 21 and 22:
Tobacco products are among the top
- Page 23 and 24:
In 2007, given estimated costs of $
- Page 25 and 26:
improved regulation, by collectivel
- Page 27 and 28:
Tobacco control strategy for Aborig
- Page 29 and 30:
Australian National Tobacco Strateg
- Page 31 and 32:
Regulation of products Possible reg
- Page 33 and 34:
• • parents/carers and children
- Page 35 and 36:
Australia in partnership with a num
- Page 37 and 38:
What needs to be achieved How The C
- Page 39 and 40:
——— 2005. 2004 National Drug
- Page 41 and 42:
Schofield PE, Borland R, Hill DJ, P
- Page 43 and 44:
In adult life, recreational (interm
- Page 45 and 46:
ehaviours as a result of public edu
- Page 47 and 48:
Screening for melanoma There is ins
- Page 49 and 50:
What needs to be achieved How The C
- Page 51 and 52:
Autier P 2004. Issues about solaria
- Page 53 and 54:
N u t r i t i o n Introduction 52 S
- Page 55 and 56:
Table 1.4 Conclusions of the major
- Page 57 and 58:
It may be possible that different t
- Page 59 and 60:
Table 1.5 Current trends in consump
- Page 61 and 62:
key stakeholders (Sorensen et al. 1
- Page 63 and 64:
A large scale randomised controlled
- Page 65 and 66:
• The International Union Against
- Page 67 and 68:
References Nutrition Agency for Hea
- Page 69 and 70:
Kushi L & Giovannucci E 2002. Dieta
- Page 71 and 72:
Strategic Inter-Governmental Nutrit
- Page 73 and 74:
How physical activity is measured U
- Page 75 and 76:
There is consistent epidemiological
- Page 77 and 78:
• • Moderate-intensity physical
- Page 79 and 80:
to help them achieve greater and mo
- Page 81 and 82:
Populations Aboriginal and Torres S
- Page 83 and 84:
An increased capacity to monitor be
- Page 85 and 86:
McTiernan A, Kooperberg C, White E,
- Page 87 and 88:
O v e r w e i g h t a n d o b e s i
- Page 89 and 90:
Table 1.9 Proportion of cancer attr
- Page 91 and 92:
were $107.3 million in 2005, with 7
- Page 93 and 94:
Obese children have a 25% to 50% ch
- Page 95 and 96:
Table 1.10 Summary of the strengths
- Page 97 and 98:
more than moderately effective. The
- Page 99 and 100:
a screening approach particularly f
- Page 101 and 102:
What needs to be achieved How The C
- Page 103 and 104:
References Overweight and obesity A
- Page 105 and 106:
Gebel K, King L, Bauman A, Vita P,
- Page 107 and 108:
——— 2004. SNAP: A population
- Page 109 and 110: (the highest level of evidence in t
- Page 111 and 112: How the amount of disease caused by
- Page 113 and 114: The challenge Adults Alcohol is a s
- Page 115 and 116: and healthy drinking cultures in Au
- Page 117 and 118: ook’) (RACGP 2006) assists in dev
- Page 119 and 120: English DR, Holman CDJ, Milne E, Hu
- Page 122 and 123: Section Two: Screening to detect ca
- Page 124 and 125: early detection improves health out
- Page 126 and 127: false positive faecal occult blood
- Page 128 and 129: 1987, compared to 51.3 deaths per 1
- Page 130 and 131: Breast self-examination Breast self
- Page 132 and 133: a significant proportion of women a
- Page 134 and 135: An Australian review of the benefit
- Page 136 and 137: References Breast cancer Australian
- Page 138 and 139: Semiglazov VF, Manikhas AG, Moiseen
- Page 140 and 141: A vaccine to prevent HPV infection
- Page 142 and 143: It is anticipated that the introduc
- Page 144 and 145: Recruitment Women in the target age
- Page 146 and 147: B o w e l ( c o l o r e c t a l ) c
- Page 148 and 149: could focus on: how to use this tim
- Page 150 and 151: Periodic testing is recommended, as
- Page 152 and 153: participate in the initial phase; t
- Page 154 and 155: likely to do so if reinvited, espec
- Page 156 and 157: What we want to achieve How The Can
- Page 158 and 159: P, Sivak MV & Butler H 2004. Comput
- Page 162 and 163: M e l a n o m a Melanoma in Austral
- Page 164 and 165: Would screening be of benefit at th
- Page 166 and 167: P r o s t a t e c a n c e r Cancer
- Page 168 and 169: have lower levels of free PSA than
- Page 170 and 171: • • a monitoring mechanism be p
- Page 172 and 173: ecause surgical patients are usuall
- Page 174 and 175: Klein EA 2004. Selenium and vitamin
- Page 176 and 177: Section Three: Immunisation www.can
- Page 178 and 179: epithelial carcinomas of the bladde
- Page 180 and 181: The challenge Stigmatisation of cer
- Page 182 and 183: The goals of a therapeutic vaccine
- Page 184 and 185: Brinkman JA, Caffrey AS, Muderspach
- Page 186 and 187: Victorian Cervical Cytology Registr
- Page 188 and 189: Chronic hepatitis B infection occur
- Page 190 and 191: Global Globally, an estimated two t
- Page 192 and 193: The rise in HCC is thought to be as
- Page 194 and 195: • • • • • • • • •
- Page 196 and 197: The policy context The bleak outcom
- Page 198 and 199: Aims What needs to be achieved How
- Page 200 and 201: Chen DS 2005. Long-term protection
- Page 202 and 203: Williams A 2002. Reduction in the h
- Page 204 and 205: Authors Dr Cleola Anderiesz BSc (Ho
- Page 206 and 207: Associate Professor John Kelly MDBS
- Page 208 and 209: A alcohol 107 - 119 aims of The Can
- Page 210 and 211:
east cancer (post-menopause) 87, 88
- Page 213:
The National Cancer Prevention Poli